These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4238955)

  • 1. [Considerations on fibrinolysis with particular reference to a biological inhibitor of plasmin].
    Coelho MC; Tim AR
    Hospital (Rio J); 1968 Jul; 74(1):307-14. PubMed ID: 4238955
    [No Abstract]   [Full Text] [Related]  

  • 2. [Considerations on fibrinolysis with special reference to a biological inhibitor of plasmin].
    Coelho MC; Tim AR
    Hospital (Rio J); 1966 Feb; 69(2):255-62. PubMed ID: 4222477
    [No Abstract]   [Full Text] [Related]  

  • 3. Differences between neonates and adults in plasmin inhibitory and antifibrinolytic action of aprotinin.
    Zenker M; Ries M
    Thromb Res; 2002 Jul; 107(1-2):17-21. PubMed ID: 12413584
    [No Abstract]   [Full Text] [Related]  

  • 4. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM; Kalnoski MH; Frederick M; Chandler WL
    Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-2 plasmin inhibitor-plasmin complex and postoperative blood loss: double-blind study with aprotinin in reoperation for myocardial revascularization.
    Minami K; Notohamiprodjo G; Buschler H; Prohaska W; Reichelt W; Körfer R
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):934-6. PubMed ID: 7694000
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents.
    Longstaff C
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):537-42. PubMed ID: 7531000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation and fibrinolytic studies following use of proteinase inhibitors in prostatic surgery.
    Phillips LL; Weiss R; Wolf C
    Ann N Y Acad Sci; 1968 Jun; 146(2):737-44. PubMed ID: 4239442
    [No Abstract]   [Full Text] [Related]  

  • 8. [Inhibition of plasmin system by 4-(2-carboxyethyl) phenyl-trans-4-aminomethyl cyclohexane carboxylate hydrochloride (DV 1006) (AUTHOR'S TRANSL)].
    Maki M
    Rinsho Ketsueki; 1972 Feb; 13(1):30-7. PubMed ID: 4281839
    [No Abstract]   [Full Text] [Related]  

  • 9. Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss.
    Flight SM; Johnson LA; Du QS; Warner RL; Trabi M; Gaffney PJ; Lavin MF; de Jersey J; Masci PP
    Br J Haematol; 2009 Apr; 145(2):207-11. PubMed ID: 19236611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the heterogeneity of activity by various types of plasmins and the spectra of inhibition of some plasmin inhibitors.
    Ambrus CM; Ambrus JL; Lassman HB; Mink IB
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):67-85. PubMed ID: 4257701
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.
    Al-Horani RA; Desai UR
    Med Res Rev; 2014 Nov; 34(6):1168-216. PubMed ID: 24659483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The fibrinolytic activity in Seegers' cattle prothrombin preparations. A contribution to the problem of the activation of cattle prothrombin by plasmin].
    Andrassy K; Egbring R; Egli H
    Thromb Diath Haemorrh; 1969 Nov; 22(2):377-90. PubMed ID: 4245334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differentiation between fibrinogenolysis and fibrinolysis products induced by plasmin].
    Maki M
    Nihon Ketsueki Gakkai Zasshi; 1967 Apr; 30(2):267-75. PubMed ID: 4229020
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of effect of fibrinolysis system on ADP- and serotonin-dependent human thrombocyte aggregation].
    Men'shikov MIu
    Biull Eksp Biol Med; 1998 Feb; 125(2):158-61. PubMed ID: 9559126
    [No Abstract]   [Full Text] [Related]  

  • 15. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin.
    Ray MJ; Marsh NA
    Thromb Haemost; 1997 Sep; 78(3):1021-6. PubMed ID: 9308747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dynamics of thrombin-antithrombin-III complex (TAT-III) and prothrombin fragments F1 + 2 during labour with and without aprotinin administration].
    Kühnert M; Stein W; Woernle F; Tekesin I; Hellmeyer L; Schmidt S
    Z Geburtshilfe Neonatol; 2004 Jun; 208(3):98-109. PubMed ID: 15229817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spectrophotometric determination of the plasmin inhibition capacity of human serum].
    Duck HJ; Wagner J
    Dtsch Gesundheitsw; 1971 Oct; 26(41):1928-31. PubMed ID: 4258754
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD
    Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibronectin--a plasmin-sensitive glycoprotein of the transit zone: protection by aprotinin.
    Heine H; Domann M
    Arzneimittelforschung; 1984; 34(6):696-8. PubMed ID: 6207847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevants of the membrane protective action of aprotinin on the intraoperative histamine liberation.
    Harke H; Rahman S
    Prog Clin Biol Res; 1989; 308():959-63. PubMed ID: 2476829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.